The influence of corticosteroids on atibacterial activity of surface active compounds.
D001407:Bacillus / Q000187:drug effects* / Q000378:metabolism; D001554:Benzene / Q000494:pharmacology; D001965:Bromides / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006854:Hydrocortisone / Q000494:pharmacology; D008365:Manometry; D008775:Methylprednisolone / Q000494:pharmacology; D063065:Organophosphonates / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects* / Q000378:metabolism; D013501:Surface-Active Agents / Q000494:pharmacology*
D001965:Bromides; D002712:Chlorides; D005938:Glucocorticoids; D063065:Organophosphonates; D000644:Quaternary Ammonium Compounds; D013501:Surface-Active Agents; D005446:Fluocinolone Acetonide; D001554:Benzene; D006854:Hydrocortisone; D008775:Methylprednisolone